Status:
COMPLETED
Acupuncture in Myasthenia Gravis (AcuMG)
Lead Sponsor:
HealthPartners Institute
Conditions:
Myasthenia Gravis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of the study is to determine the effect acupuncture treatment on individuals with a diagnosis of Myasthenia Gravis (MG). A total of 20 people with MG will be enrolled in this study to rece...
Eligibility Criteria
Inclusion
- Ability to provide and provision of signed and dated informed consent form
- Age 18-80
- Diagnosis of MG
Exclusion
- Non-English speaking
- Participation in acupuncture treatment outside of the study, while enrolled
- History of any other serious neurological, psychiatric, chronic pain disorders, or seizures
- History of bleeding diathesis, other bleeding disorders, or syncope with needle puncture
- History of cardiac arrhythmia or current pacemaker, neurostimulator, or other implanted stimulation device
- Recent or active substance use disorder
- Women who are currently pregnant, lactating, or planning to become pregnant during the study
- Any other medical conditions that could affect their ability to participate in acupuncture treatments for the study duration (as determined by study investigators)
- Active participation or past participation ≤3 months in any other interventional study.
- Unwilling to participate in all study related activities
Key Trial Info
Start Date :
May 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05230082
Start Date
May 25 2022
End Date
April 30 2024
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HealthPartners Neuroscience Center
Saint Paul, Minnesota, United States, 55130